Prevention and Treatment of Seasonal Asthmatic Patients by Combined Invigorating Kidney for Preventing Asthma Tablets and Beclomethasone Dipropinate  

Prevention and Treatment of Seasonal Asthmatic Patients by Combined Invigorating Kidney for Preventing Asthma Tablets and Beclomethasone Dipropinate

在线阅读下载全文

作  者:徐东 许仁和 

出  处:《Chinese Journal of Integrative Medicine》1998年第1期28-28,共0页中国结合医学杂志(英文版)

摘  要:Objective: To evaluate the efficacy ofcombined invigorating Kidney for PreventingAsthma (IKPA) tablets and beclomethasonedipropinate (BDP ). Methods: Fifty--sevenseasonal asthmatic patients were studied.They were randomly assigned to either of thetwo groups f the treated group (n = 32) treated with the IKPA tablets and inhalated BDP,the control group (n = 25) inhalated BDPsingly. Measurements of serum eosinophilcationic protein (ECP), soluble II---2 receptor(SIL--2 ) t total eosinophil counts, spirometryand methacholine challenge were performedbefore and after treatment. Results: After 3months ) treatment and 6 months ) observationthe authors observed a significant improvementin both groups. The treated group had betterclinical efficacy and the ECP level had reducedsignificantly, FEVI increased greatly than thecontrol group. Conclusions: The two drugsinfluenced the function of eosinophils and Tlymphocytes and this might contribute to theefficacy.Objective: To evaluate the efficacy ofcombined invigorating Kidney for PreventingAsthma (IKPA) tablets and beclomethasonedipropinate (BDP ). Methods: Fifty--sevenseasonal asthmatic patients were studied.They were randomly assigned to either of thetwo groups f the treated group (n = 32) treated with the IKPA tablets and inhalated BDP,the control group (n = 25) inhalated BDPsingly. Measurements of serum eosinophilcationic protein (ECP), soluble II---2 receptor(SIL--2 ) t total eosinophil counts, spirometryand methacholine challenge were performedbefore and after treatment. Results: After 3months ) treatment and 6 months ) observationthe authors observed a significant improvementin both groups. The treated group had betterclinical efficacy and the ECP level had reducedsignificantly, FEVI increased greatly than thecontrol group. Conclusions: The two drugsinfluenced the function of eosinophils and Tlymphocytes and this might contribute to theefficacy.

分 类 号:R562.25[医药卫生—呼吸系统]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象